World Journal of Emergency Medicine ›› 2014, Vol. 5 ›› Issue (2): 96-102.doi: 10.5847/wjem.j.issn.1920-8642.2014.02.003
• Original Articles • Previous Articles Next Articles
Hua Zhou(), Xiao-yan He, Shao-wei Zhuang, Juan Wang, Yan Lai, Wei-gang Qi, Yi-an Yao, Xue-bo Liu
Received:
2013-11-03
Accepted:
2014-04-16
Online:
2014-06-15
Published:
2014-06-15
Contact:
Hua Zhou
E-mail:zhzju0560@sohu.com
Hua Zhou, Xiao-yan He, Shao-wei Zhuang, Juan Wang, Yan Lai, Wei-gang Qi, Yi-an Yao, Xue-bo Liu. Clinical and procedural predictors of no-reflow in patients with acute myocardial infarction after primary percutaneous coronary intervention[J]. World Journal of Emergency Medicine, 2014, 5(2): 96-102.
Add to citation manager EndNote|Ris|BibTeX
URL: http://wjem.com.cn//EN/10.5847/wjem.j.issn.1920-8642.2014.02.003
Table 1
Basline clinical data in the reflow group and the no-reflow group (n, %)
Variables | Reflow (n=258) | No-reflow (n=54) | t/χ2 value | P value |
---|---|---|---|---|
Age(yr) | 61.1±12.4 | 67.1±14.9 | 24.703 | <0.01 |
Male | 160 (62.0) | 38 (70.3) | 1.682 | 0.324 |
Hypertension | 94 (36.4) | 23 (42.5) | 1.152 | 0.224 |
Diabetes mellitus | 41 (15.9) | 10 (18.5) | 0.438 | 0.635 |
Hypercholesterolemia | 121 (46.9) | 29 (53.7) | 1.652 | 0.174 |
Current smoker | 90 (34.8) | 20 (37.0) | 1.120 | 0.295 |
Family history of CAD | 88 (34.1) | 19 (35.2) | 0.436 | 0.829 |
Previous MI | 13 (5.0) | 3 (5.6) | 0.024 | 0.660 |
Pre-infarction angina | 78 (30.3) | 17 (31.4) | 0.576 | 0.841 |
Infarct loction | ||||
Anterior | 157 (60.8) | 36 (66.7) | ||
Inferior | 79 (30.6) | 14 (25.9) | 1.832 | 0.494 |
Other locations | 22 (8.6) | 4 (7.4) | ||
Physical findings on admission | ||||
SBP (mmHg) | 116.2±22.4 | 101.2±25.8 | 24.734 | <0.001 |
DBP (mmHg) | 71.4±13.4 | 66.1±16.8 | 9.973 | 0.050 |
Peak CK-MB (U/L) | 160±166 | 239±205 | 11.762 | 0.014 |
Reperfusion time (h) | 5.4±2.8 | 6.7±3.2 | 5.678 | 0.011 |
Killip classes (%) | 9.653 | 0.02 | ||
1 | 176 (68.2) | 24 (44.4) | ||
2 | 64 (24.8) | 20 (37) | ||
3 | 13 (5.0) | 2 (3.7) | ||
4 | 5 (2) | 8 (14.9) | ||
IABP use before PCI (%) | 20 (7.8) | 14 (25.9) | 42.8 | <0.0001 |
Table 2
Angiographic and surgical data in the reflow group and the no-reflow group (n, %)
Variables | Reflow (n=258) | No-reflow (n=54) | t/χ2 value | P value |
---|---|---|---|---|
Multivessel disease | 138 (53.5) | 32 (59.3) | 0.873 | 0.326 |
IRA | 1.743 | 0.568 | ||
LAD | 152 (58.9) | 36 (66.7) | ||
LCX | 23 (8.9) | 4 (7.4) | ||
RCA | 83 (32.1) | 14 (25.9) | ||
Initial TIMI flow | 32.742 | 0.0007 | ||
0/1 | 180 (69.8) | 50 (92.6) | ||
2/3 | 78 (30.2) | 4 (7.4) | ||
Target lesion location | 1.172 | 0.386 | ||
Proximal | 93 (36.0) | 21 (38.9) | ||
Mid | 159 (61.6) | 30 (55.6) | ||
Distal | 6 (2.4) | 3 (5.5) | ||
Type of occlusion | ||||
Subtotal | 103(39.9) | 11 (20.3) | ||
Tapered | 80 (31.0) | 20 (37.1) | 9.763 | 0.024 |
Cut-off | 75 (29.1) | 23 (42.6) | ||
Lesion types in subtotal occlusion | 1.362 | 0.428 | ||
Eccentric | 23 (22.3) | 4 (36.4) | ||
Concentric | 80 (77.7) | 7 (63.7) | ||
Target lesion length (mm) | 18±6.48 | 21.6±9.25 | 8.324 | <0.0001 |
Reference diameter (mm) | 3.1±0.3 | 3.3±0.4 | 2.213 | 0.029 |
Thrombus burden | 23.762 | 0.010 | ||
Low | 70 (27.1) | 9 (16.7) | ||
Moderate | 75 (29) | 12 (22.2) | ||
High | 113 (43.9) | 33 (61.1) | ||
Good collateral flow | 16 (6.2) | 4 (7.4) | 0.532 | 0.635 |
Method of reperfusion | 7.634 | 0.002 | ||
Balloon angioplasty | 9 (3.4) | 4 (7.4) | ||
Stenting after pre-dilation | 163 (63.2) | 44 (81.4) | ||
Direct stenting | 86 (33.4) | 6 (11.2) | ||
Repeated balloon dilatations (≥2) | 79 (30.6) | 23 (42.6) | 2.384 | 0.054 |
Multiple stents (≥2) | 43 (16.7) | 15 (27.8) | 2.765 | 0.051 |
Aspiration thrombetomy | 164 (63.5) | 32 (59.3) | 0.876 | 0.628 |
Tirofiban use | 180 (69.8) | 40 (74) | 0.435 | 0.644 |
Table 3
Independent predictors of no-reflow phenomenon shown by univariate and multivariate analyses
Variables | Univariate analysis | Multivariate analysis | |||
---|---|---|---|---|---|
P value | OR (95%CI) | P value | OR (95%CI) | ||
Age (>65 yr) | <0.0001 | 1.884 (1.830-1.980) | 0.007 | 1.470 (1.460-1.490) | |
Reperfusion time (>6 hours) | 0.005 | 1.564 (1.362-1.872) | 0.001 | 1.270 (1.16-1.40) | |
SBP on admission <100 mmHg | 0.005 | 1.570 (1.390-1.850) | 0.004 | 1.910 (1.018-3.896) | |
IABP use before PCI | 0.003 | 1.879 (1.152-3.172) | 0.011 | 1.949 (1.160-3.253) | |
Initial TIMI flow (0-1) | 0.002 | 1.112 (1.083-1.236) | <0.001 | 1.100 (1.080-1.250) | |
High thrombus burden | 0.020 | 1.423 (1.062-1.854) | 0.030 | 1.600 (1.470-2.760) | |
Long target lesion | 0.027 | 1.269 (1.156-1.405) | 0.019 | 1.948 (1.908-1.990) |
1 |
Gibson CM, de Lemos JA, Murphy SA, Marble SJ, McCabe CH, Cannon CP, et al. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy. Circulation 2001; 103:2550-2554.
doi: 10.1161/01.cir.103.21.2550 pmid: 11382722 |
2 |
Kirma C, Izgi A, Dundar C, Tanalp AC, Oduncu V, Aung SM, et al. Clinical and prodedural predictors of no-reflow phenomenon after primary percutaneous coronary interventions: experience at a single center. Circ J 2008; 72:716-721.
pmid: 18441449 |
3 |
Reffelmann T, Kloner RA. The "no-reflow" phenomenon: basic science and clinical correlates. Heart 2002; 87:162-168.
doi: 10.1136/heart.87.2.162 pmid: 11796561 |
4 |
Wang CH, Chen YD, Yang XC, Wang LF, Wang HS, Sun ZJ, et al. A no-reflow prediction model in patients with ST-elevation acute myocardial infarction and primary drug-eluting stenting. Scand Cardiovasc J 2011; 45:98-104
doi: 10.3109/14017431.2011.558209 pmid: 21329416 |
5 |
Lowe GD, Rumley A, Woodward M, Morrison CE, Philippou H, Lane DA, et al. Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Survey. I. Illustrative reference ranges by age, sex and hormone use. Br J Haematol 1997; 97:775-784.
doi: 10.1046/j.1365-2141.1997.1222936.x pmid: 9217176 |
6 |
Kirma C, Izgi A, Dundar C, Tanalp AC, Oduncu V, Aung SM, et al. Clinical and procedural predictors of no-reflow phenomenon after primary percutaneous coronary interventions: experience at a single center. Circ J 2008; 72:716-721.
doi: 10.1253/circj.72.716 pmid: 18441449 |
7 |
Hearse DJ, Bolli R. Reperfusion induced injury: manifestations, mechanisms, and clinical relevance. Cardiovasc Res 1992; 26:101-108.
doi: 10.1093/cvr/26.2.101 pmid: 1571929 |
8 |
Ali A, Cox D, Dib N, Brodie B, Berman D, Gupta N, et al. Rheolytic thrombectomy with percutaneous coronary intervention for infarct size reduction in acute myocardial infarct size reduction in acute myocardial infarction:30-day results from a multicenter randomized study. J Am Coll Cardiol 2006; 48:244-252.
doi: 10.1016/j.jacc.2006.03.044 pmid: 16843170 |
9 |
Nagata Y, Usuda K, Uchiyama A, Uchikoshi M, Sekiguchi Y, Kato H, et al. Characteristics of the pathological images of coronary artery thrombi according to the infarct-related coronary artery in acute myocardial infarction. Circ J 2004; 68:308-314.
doi: 10.1253/circj.68.308 pmid: 15056826 |
10 |
Yip HK, Chen MC, Chang HW, Hang CL, Hsieh YK, Fang CY, et al. Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: predictors of slow-flow and no-flow. Chest 2002; 122:1322-1332.
doi: 10.1378/chest.122.4.1322 pmid: 12377860 |
11 |
De Luca G, Suryapranata H, Zijlstra F, van 't Hof AW, Hoorntje JC, Gosselink AT, et al. Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty. J Am Coll Cardiol 2003; 42:991-997.
doi: 10.1016/s0735-1097(03)00919-7 pmid: 13678918 |
12 |
De Luca G, Ernst N, Zijlstra F, van 't Hof AW, Hoorntje JC, Dambrink JH, et al. Preprocedural TIMI flow and mortality in patients with acute myocardial infarction treated by primary angioplasty. J Am Coll Cardiol 2004; 43:1363-1367.
doi: 10.1016/j.jacc.2003.11.042 pmid: 15093868 |
13 |
Zeymer U, Zahn R, Schiele R, Jansen W, Girth E, Gitt A, et al. Early epifibatide improves TIMI 3 patency before primary percutaneous coronary intervention for acute ST elevation myocardial infarction: Results of randomized integrilin in acute myocardial infarction (INTAMI) pilot trial. Eur Heart J 2005; 26:1971-1977.
doi: 10.1093/eurheartj/ehi293 pmid: 15857851 |
14 |
Lee KL, Woodlief LH, Topol EJ, Weaver WD, Betriu A, Col J, et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction: results from an international trialof 41021 patients. GUSTO-I Investigators. Circulation 1995; 91:1659-1668.
doi: 10.1161/01.cir.91.6.1659 pmid: 7882472 |
15 |
Ishikura F, Miki A, Iwata A, Toshida T, Shakudo M, Asanuma T, et al. Effect of systemic blood pressure in microcollateral circulation evaluated by real-time contrast echocardiography. J Am Soc Echocardiogr 2008; 21:765-769.
doi: 10.1016/j.echo.2007.10.005 pmid: 18187304 |
16 |
Chen Y, Wang C, Yang X, Wang L, Sun Z, Liu H, et al. Independent no-reflow predictors in female patients with ST-elevation acute myocardial infarction treated with primary percutaneous coronary intervention. Heart Vessels 2012; 27:243-249.
pmid: 21526420 |
17 |
Movahed MR, Butman SM. The pathogenesis and treatment of no-reflow occurring during percutaneous coronary intervention. Cardiovasc Revasc Med 2008; 9:56-61.
doi: 10.1016/j.carrev.2007.08.005 pmid: 18206640 |
18 |
De Luca G, Gibson CM, Huber K, Zeymer U, Dudek D, Cutlip D, et al. Association between advanced Killip class ar presentation and impaired myocardial infarction treated with primary angioplasty and adjunctive glycoprotein IIb-IIIa inhibitors. Am Heart J 2009; 158:416-421.
pmid: 19699865 |
19 |
Skyschally A, Erbel R, Heusch G. Coronary microembolization. Circ J 2003; 67:279-286.
doi: 10.1253/circj.67.279 pmid: 12655156 |
20 | Claeys MJ, Bosmans J, De Ceuninck M, Beunis A, Vergauwen W, Vorlat A, et al. Effect of intracoronary adenosine infusion during coronary intervention on myocardial reperfusion injury in patients with acute myocardial infarction. Am J Cardiology 2004; 94:9-13. |
21 |
Watanabe T, Nanto S, Uematsu M, Ohara T, Morozumi T, Kotani J, et al. Prediction of no-reflow phenomenon after successful percutaneous coronary intervention in patients with acute myocardial infarction: intravascular ultrasound findings. Circ J 2003; 67:667-671.
doi: 10.1253/circj.67.667 pmid: 12890907 |
22 |
Tanaka A, Kawarabayashi T, Nishibori Y, Sano T, Nishida Y, Fukuda D, et al. No-reflow phenomenon and lesion morphology in patients with acute myocardial infarction. Circulation 2002; 105:2148-2152.
doi: 10.1161/01.cir.0000015697.59592.07 pmid: 11994247 |
23 |
Katayama T, Kubo N, Takagi Y, Funayama H, Ikeda N, Ishida T, et al. Relation of atherothrombosis burden and volume detected by intravascular ultrasound to angiographic no-reflow phenomenon during stent implantation in patients with acute myocardial infarction. Am J Cardiol 2006; 97:301-304.
doi: 10.1016/j.amjcard.2005.08.043 pmid: 16442385 |
24 |
Bae JH, Kwon TG, Hyun DW, Rihal CS, Lerman A. Predictors of slow flow during primary percutaneous coronary intervention:an intravascular ultrasound virtual histology study. Heart 2008; 94:1559-1564.
doi: 10.1136/hrt.2007.135822 pmid: 18381376 |
25 |
Antoniucci D, Valenti R, Migliorini A, Moschi G, Bolognese L, Cerisano G, et al. Direct infarct artery stenting without predilation and no-reflow in patients with acute myocardial infarction. Am Heart J 2001; 142:684-690.
doi: 10.1067/mhj.2001.117778 pmid: 11579360 |
26 |
Umeda H, Katoh T, Iwase M, Izawa H, Nagata K, Watanabe K, et al. The distal protection during primary percutaneous coronary intervention alleviates the adverse effects of large thrombus burden on myocardial reperfusion. Circ J 2006; 70:232-238.
doi: 10.1253/circj.70.232 pmid: 16501285 |
[1] | Hai-mu Yao, Tong-wen Sun, You-dong Wan, Xiao-juan Zhang, Xin Fu, De-liang Shen, Jin-ying Zhang, Ling Li. Domestic versus imported drug-eluting stents for the treatment of patients with acute coronary syndrome [J]. World Journal of Emergency Medicine, 2014, 5(3): 175-181. |
[2] | Li-ming Li, Wen-bo Cai, Qin Ye, Jian-min Liu, Xin Li, Xiao-xing Liao. Comparison of plasma microRNA-1 and cardiac troponin T in early diagnosis of patients with acute myocardial infarction [J]. World Journal of Emergency Medicine, 2014, 5(3): 182-186. |
[3] | Jing-xia Zhang, Yong-li Chen, Yu-ling Zhou, Qian-yu Guo, Xian-pei Wang. Expression of tissue factor in rabbit pulmonary artery in an acute pulmonary embolism model [J]. World Journal of Emergency Medicine, 2014, 5(2): 144-147. |
[4] | Li-li Ji, Xiao-feng Long, Hui Tian, Yu-fei Liu. Effect of transplantation of bone marrow stem cells on myocardial infarction size in a rabbit model [J]. World Journal of Emergency Medicine, 2013, 4(4): 304-310. |
[5] | Yan Chen, Wei Yang, Gan-nan Wang, Jun Li, Xiao-rong Li, Jian Zhang, Wei Yuan, Dao-wu Wang, Jin-song Zhang, Ke-jiang Cao. Circulating microRNAs, novel biomarkers of acute myocardial infarction: a systemic review [J]. World Journal of Emergency Medicine, 2012, 3(4): 257-260. |
[6] | Xiao-dong Liu, Chun-lei Sun, Su-ping Mu, Xiao-mei Qiu, Hai-ying Yu. Acute myocardial infarction in a child with myocardial bridge [J]. World Journal of Emergency Medicine, 2011, 2(1): 70-72. |
[7] | Yu Chen, Zhi-jian Chen, Yu-hua Liao, Zhe Cao, Jia-ding Xia, Hua Yang, Yi-mei Du. Effect of tumor necrosis factor-α on ventricular arrhythmias in rats with acute myocardial infarction in vivo [J]. World Journal of Emergency Medicine, 2010, 1(1): 53-58. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||